Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINOZA: Zevalin with BEAM for Relapsed DLBCL
NCT00491491Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- Jun 2007
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of ibritumomab tiuxetan in diffuse large B-cell lymphoma (DLBCL), sponsored by Sheba Medical Center. Started Jun 2007; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00491491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491491.